Related Experiment Video
Updated: Jun 15, 2026
09:02
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
[Hepatitis B virus and chronic progressive kidney disease]
1Department of Dialysis, Zagreb University Hospital Center, Zagreb, Croatia.
Summary
Hepatitis B virus (HBV) infection in dialysis patients has declined, but remains a concern. Prevention strategies include vaccination, strict precautions, and antiviral therapies to manage HBV in renal disease and post-transplant patients.
Area of Science:
- Nephrology
- Hepatology
- Infectious Diseases
Context:
- Hepatitis B virus (HBV) infection poses unique challenges in end-stage renal disease (ESRD) patients due to immunosuppression and transmission risks.
- Despite declining prevalence, HBV infection requires vigilant management in dialysis settings and post-kidney transplantation.
Purpose:
- To outline current strategies for preventing and managing hepatitis B virus infection in patients with end-stage renal disease.
- To discuss the implications of HBV infection on renal disease, treatment options, and post-transplant outcomes.
Summary:
- Prevalence of HBV infection in dialysis patients has decreased, necessitating rigorous standard and hemodialysis-specific precautions, alongside vaccination for patients and staff.
- Treatment decisions for chronic HBV hinge on assessing viral replication and liver disease activity, with options including interferon-alfa, nucleoside/nucleotide analogues, or observation.
- Preventive or preemptive antiviral strategies are crucial for HBV-infected kidney transplant recipients to mitigate reactivation risks. HBV can also be linked to specific renal diseases, requiring antiviral therapy and potentially glucocorticoids.
Impact:
- Improved understanding of HBV management in ESRD patients, guiding clinical practice and public health initiatives.
- Highlights the importance of vaccination and tailored antiviral therapies in reducing HBV-related morbidity and mortality in vulnerable populations.
- Provides insights into the complex interplay between HBV infection and renal pathology, informing diagnostic and therapeutic approaches.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...